Study analysis consisted of comparing ivermectin users with non-users using cohorts of infected patients propensity score-matched by age, sez, and comorbidities. COVID-19 infection and mortality rates were analyzed with and without the use of propensity score matching (PSM).
Results:
There was a with a 44% reduction in COVID-19 infection rate for the cohorts using ivermectin prophylactically (p < 0.0001).
The regular use of ivermectin led to a 68% reduction in COVID-19 mortality (p < 0.0001). When adjusted for residual variables, reduction in mortality rate was 70% (p < 0.0001).
There was a 56% reduction in hospitalization rate among ivermectin users and non-users, respectively (p < 0.0001). After adjustment for residual variables, reduction in hospitalization rate was 67% (p < 0.0001).
Conclusion (from the study): In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.
Obviously, this is an important study and validates the anecdotal data from various African countries where ivermectin is given prophylactically and incidence of COVID is very low (knowing that there are lots of confounding variables such has age, weight and vitamin D3 levels found in many of these countries).
rwmalonemd.substack.com
Results:
There was a with a 44% reduction in COVID-19 infection rate for the cohorts using ivermectin prophylactically (p < 0.0001).
The regular use of ivermectin led to a 68% reduction in COVID-19 mortality (p < 0.0001). When adjusted for residual variables, reduction in mortality rate was 70% (p < 0.0001).
There was a 56% reduction in hospitalization rate among ivermectin users and non-users, respectively (p < 0.0001). After adjustment for residual variables, reduction in hospitalization rate was 67% (p < 0.0001).
Conclusion (from the study): In this large PSM study, regular use of ivermectin as a prophylactic agent was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.
Obviously, this is an important study and validates the anecdotal data from various African countries where ivermectin is given prophylactically and incidence of COVID is very low (knowing that there are lots of confounding variables such has age, weight and vitamin D3 levels found in many of these countries).
Ivermectin and More in the News
COVID-19: A Second Opinion Senator Ron Johnson Published January 24, 2022 416,684 Views https://rumble.com/vt62y6-covid-19-a-second-opinion.html Please share this video with family and friends. Yes, it is five hours long but well worth the watch! Discussion begins around 40 minute mark. Sen. Ron...
rwmalonemd.substack.com
